The triple stack: tirzepatide plus AOD 9604 plus additional peptides Some aggressive protocols add additional compounds like MOTS-c (mitochondrial peptide for metabolic optimization) or 5-amino-1MQ (fat metabolism enhancer)
The combination is most useful for patients with one or more of the following: BMI of 30 or higher , or BMI 27 with at least one weight-related condition such as type 2 diabetes, hypertension, or sleep apnea History of fatigue, low mood, or brain fog on previous diets or weight loss attempts Metformin use for type 2 diabetes or pre-diabetes (chronic metformin reduces B12) Long-term proton pump inhibitor use such as omeprazole, pantoprazole, or lansoprazole Vegetarian or vegan diet with limited animal protein intake Adults over 50 , where B12 absorption naturally declines Active strength training or higher physical demands while on a calorie deficit Patients who dont fit any of these profiles can still take semaglutide alone, then add B12 if symptoms suggest it
A large protein, BPC was claimed in a 1994 US patent (#5,288,708) to have been isolated from both human and animal gastric juice and to exert a wide-range of protective effects in organ injury models
It did not confirm chain of custody, repeat the analysis, authenticate the lab, or verify the lab's accreditation status